Biodexa Pharmaceuticals (BDRX) Debt Ratio (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) posted Debt Ratio of 0.69 for Q4 2025, up 1935.2% sequentially from 0.03 in Q2 2025, and up 7.93% YoY from 0.64 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Debt Ratio (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has reported Debt Ratio for 13 years, with the latest figure at 0.69 in Q4 2025.
- Quarterly Debt Ratio rose 7.93% year-over-year to 0.69 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.69 (up 7.93% YoY) and the FY2025 annual result came in at 0.69, up 7.93% from the prior year.
- Debt Ratio advanced to 0.69 in Q4 2025 per BDRX's latest filing, from 0.03 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.92 in Q4 2021 and troughed at 0.01 in Q2 2024.
- A 5-year average of 0.57 and a median of 0.69 in 2025 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2023 and 2025: Debt Ratio plunged 92.39% in 2023, then surged 126.96% in 2025.
- Over 5 years, Debt Ratio stood at 0.92 in 2021, then dropped by 4.82% to 0.88 in 2022, then dropped by 22.19% to 0.68 in 2023, then retreated by 6.68% to 0.64 in 2024, then gained by 7.93% to 0.69 in 2025.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.69, 0.03, and 0.64 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | 0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.69 |
| Jun 30, 2025 | 0.03 |
| Dec 31, 2024 | 0.64 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2023 | 0.68 |
| Jun 30, 2023 | 0.07 |
| Dec 31, 2022 | 0.88 |
| Jun 30, 2022 | 0.90 |
| Dec 31, 2021 | 0.92 |
| Jun 30, 2021 | 0.85 |
| Dec 31, 2020 | 0.97 |
| Jun 30, 2020 | 0.86 |
| Dec 31, 2019 | 0.57 |
| Jun 30, 2019 | 0.06 |
| Dec 31, 2018 | 0.74 |
| Jun 30, 2018 | 0.57 |
| Dec 31, 2017 | 0.63 |
| Jun 30, 2017 | 0.74 |
| Dec 31, 2016 | 0.04 |
| Jun 30, 2016 | 0.80 |